ClinicalTrials.Veeva

Menu

Percutaneous Injection Plus Short Segment Pedicle Screw Fixation for Traumatic A2 and A3 AO-type Fractures in Adults (NEOGEL)

U

University Hospital of Patras

Status

Completed

Conditions

Thoracic Fracture
Lumbar Fracture

Treatments

Procedure: VP

Study type

Observational

Funder types

Other

Identifiers

NCT03431519
2018NEOGEL

Details and patient eligibility

About

The aim of this study was to examine the short- to medium-term efficacy of percutaneous vertebral body reconstruction by vertebral body augmentation with Sr-HA paste plus short-segment pedicle screw fixation in fresh fractures, as well as to evaluate Sr-HA resorption/substitution. The hypotheses tested in this study were as follows: 1) whether Sr-HA is equivalent to PMMA for restoring the fractured thoracolumbar vertebral body, 2) whether leakage of Sr-HA is less than that of PMMA, and 3) whether Sr-HA is completely resorbed and replaced by cancellous bone.

Full description

Introduction Polymethacrylate (PMMA) is commonly used in vertebroplasty and balloon kyphoplasty, but its use has been associated with complications. This study tests three hypotheses: 1) whether strontium hydroxyapatite (Sr-HA) is equivalent to PMMA for restoring thoracolumbar vertebral body fractures, 2) if incidence of PMMA leakage is similar to that of Sr-HA leakage, and 3) whether Sr-HAis resorbed and substituted by new vertebral bone.

Materials and Methods Two age- and sex-matched groups received short percutaneous pedicle screw fixation plus PEEK implant (Kiva, VCF Treatment System, Benvenue Medical, Santa Clara, CA, USA) filled with either Sr-HA (Group A) or PMMA (Group B) after A2- and A3/AO-type thoracolumbar vertebral body fractures. Visual Analog Scale (VAS) score and imaging parameters, which included segmental kyphosis angle (SKA), vertebral body height ratios (VBHr), spinal canal encroachment (SCE), bone cement leakage, and Sr-HA resorption, were compared between the two groups.

Enrollment

38 patients

Sex

Female

Ages

38 to 53 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • One single, severely (>40%) compressed A2 and A3/AO-type thoracolumbar (T10-L3) fracture
  • No other serious concomitant injuries

Exclusion criteria

  • Polytrauma
  • Neurologic impairment
  • Spinal deformity
  • Known malignancy
  • Previous fracture or surgery in the same or adjacent vertebrae

Trial design

38 participants in 2 patient groups

Group A
Description:
The subjects received VP with PEEK and Sr-HA
Treatment:
Procedure: VP
Group B
Description:
The subjects received VP with PEEK and PMMA
Treatment:
Procedure: VP

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems